UNIVERSITY OF CALIFORNIA, SAN DIEGO
Development of photocaged DREADD agonists for high-efficiency, target-specific optical silencing of synaptic transmission
Development of photocaged DREADD agonists for high-efficiency, target-specific optical silencing of synaptic transmission is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN DIEGO, up to 967201, closing January 31, 2028.
Jan 31, 2028
(549d left)Overview
Genetically-encoded tools that provide researchers with a means to control neural activity in genetically-defined cell types are widely used to establish causal relationships between neural activity and behavior. Current tools for silencing synaptic output in a way that is restricted to anatomically-defined target…